1ktc

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1ktc" size="450" color="white" frame="true" align="right" spinBox="true" caption="1ktc, resolution 2.40&Aring;" /> '''The Structure of alp...)
Line 1: Line 1:
-
[[Image:1ktc.gif|left|200px]]<br /><applet load="1ktc" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1ktc.gif|left|200px]]<br /><applet load="1ktc" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1ktc, resolution 2.40&Aring;" />
caption="1ktc, resolution 2.40&Aring;" />
'''The Structure of alpha-N-Acetylgalactosaminidase'''<br />
'''The Structure of alpha-N-Acetylgalactosaminidase'''<br />
==Overview==
==Overview==
-
In the lysosome, glycosidases degrade glycolipids, glycoproteins, and, oligosaccharides. Mutations in glycosidases cause disorders characterized, by the deposition of undegraded carbohydrates. Schindler and Fabry, diseases are caused by the incomplete degradation of carbohydrates with, terminal alpha-N-acetylgalactosamine and alpha-galactose, respectively., Here we present the X-ray structure of alpha-N-acetylgalactosaminidase, (alpha-NAGAL), the glycosidase that removes alpha-N-acetylgalactosamine, and the structure with bound ligand. The active site residues of, alpha-NAGAL are conserved in the closely related enzyme a-galactosidase A, (alpha-GAL). The structure demonstrates the catalytic mechanisms of both, enzymes and reveals the structural basis of mutations causing Schindler, and Fabry diseases. As alpha-NAGAL and alpha-GAL produce type O "universal, donor" blood from type A and type B blood, the alpha-NAGAL structure will, aid in the engineering of improved enzymes for blood conversion.
+
In the lysosome, glycosidases degrade glycolipids, glycoproteins, and oligosaccharides. Mutations in glycosidases cause disorders characterized by the deposition of undegraded carbohydrates. Schindler and Fabry diseases are caused by the incomplete degradation of carbohydrates with terminal alpha-N-acetylgalactosamine and alpha-galactose, respectively. Here we present the X-ray structure of alpha-N-acetylgalactosaminidase (alpha-NAGAL), the glycosidase that removes alpha-N-acetylgalactosamine, and the structure with bound ligand. The active site residues of alpha-NAGAL are conserved in the closely related enzyme a-galactosidase A (alpha-GAL). The structure demonstrates the catalytic mechanisms of both enzymes and reveals the structural basis of mutations causing Schindler and Fabry diseases. As alpha-NAGAL and alpha-GAL produce type O "universal donor" blood from type A and type B blood, the alpha-NAGAL structure will aid in the engineering of improved enzymes for blood conversion.
==About this Structure==
==About this Structure==
-
1KTC is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus] with NAG, NGA, SO4, GOL and ACY as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Alpha-N-acetylgalactosaminidase Alpha-N-acetylgalactosaminidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.49 3.2.1.49] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1KTC OCA].
+
1KTC is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=NGA:'>NGA</scene>, <scene name='pdbligand=SO4:'>SO4</scene>, <scene name='pdbligand=GOL:'>GOL</scene> and <scene name='pdbligand=ACY:'>ACY</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Alpha-N-acetylgalactosaminidase Alpha-N-acetylgalactosaminidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.49 3.2.1.49] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1KTC OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Gallus gallus]]
[[Category: Gallus gallus]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Garboczi, D.N.]]
+
[[Category: Garboczi, D N.]]
-
[[Category: Garman, S.C.]]
+
[[Category: Garman, S C.]]
[[Category: Hannick, L.]]
[[Category: Hannick, L.]]
[[Category: Zhu, A.]]
[[Category: Zhu, A.]]
Line 27: Line 27:
[[Category: protein-ligand complex]]
[[Category: protein-ligand complex]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 19:50:50 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:37:42 2008''

Revision as of 11:37, 21 February 2008


1ktc, resolution 2.40Å

Drag the structure with the mouse to rotate

The Structure of alpha-N-Acetylgalactosaminidase

Overview

In the lysosome, glycosidases degrade glycolipids, glycoproteins, and oligosaccharides. Mutations in glycosidases cause disorders characterized by the deposition of undegraded carbohydrates. Schindler and Fabry diseases are caused by the incomplete degradation of carbohydrates with terminal alpha-N-acetylgalactosamine and alpha-galactose, respectively. Here we present the X-ray structure of alpha-N-acetylgalactosaminidase (alpha-NAGAL), the glycosidase that removes alpha-N-acetylgalactosamine, and the structure with bound ligand. The active site residues of alpha-NAGAL are conserved in the closely related enzyme a-galactosidase A (alpha-GAL). The structure demonstrates the catalytic mechanisms of both enzymes and reveals the structural basis of mutations causing Schindler and Fabry diseases. As alpha-NAGAL and alpha-GAL produce type O "universal donor" blood from type A and type B blood, the alpha-NAGAL structure will aid in the engineering of improved enzymes for blood conversion.

About this Structure

1KTC is a Single protein structure of sequence from Gallus gallus with , , , and as ligands. Active as Alpha-N-acetylgalactosaminidase, with EC number 3.2.1.49 Full crystallographic information is available from OCA.

Reference

The 1.9 A structure of alpha-N-acetylgalactosaminidase: molecular basis of glycosidase deficiency diseases., Garman SC, Hannick L, Zhu A, Garboczi DN, Structure. 2002 Mar;10(3):425-34. PMID:12005440

Page seeded by OCA on Thu Feb 21 13:37:42 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools